| Paula A Loehr, CRNA | |
|
715 N Saint Joseph Ave, Hastings, NE 68901-4451 | |
| (402) 463-9841 | |
| Not Available |
| Full Name | Paula A Loehr |
|---|---|
| Gender | Female |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 17 Years |
| Location | 715 N Saint Joseph Ave, Hastings, Nebraska |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1538385000 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | 100981 (Nebraska) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mary Lanning Healthcare | Hastings, NE | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| The Mary Lanning Memorial Hospital Association | 4587575550 | 117 |
News Archive
Patrick S. Smith, President and Chief Executive Officer of Curaxis Pharmaceutical Corp., today announced Curaxis' new listing on the Frankfurt Stock Exchange (FSE). Curaxis was at the FSE for its opening on February 8, 2011, and will trade under the symbol 8CX:GR.
Oxygen levels in the lab can permanently alter human embryonic stem (ES) cells, specifically inducing X chromosome inactivation in female cells, according to Whitehead Institute researchers. Human ES cells have been routinely created and maintained at atmospheric levels of oxygen, which is about 20%. Cells in the body are usually exposed to only 1-9% oxygen.
Rare inherited mutations in the body's master regulator of the DNA repair system – the TP53 gene – can leave people at a higher risk of developing multiple types of cancer over the course of their lives.
One reason cancer is so difficult to treat is that it avoids detection by the body. Agents of the immune system are constantly checking the surfaces of cells for chemical signals that say they belong, but cancer cells express the same chemical signals as healthy ones.
Findings from a study published in the current issue of the journal Archives of Internal Medicine, when "taken together with other studies published over the last few years," show that beginning people living with HIV on highly active antiretroviral therapy (HAART) when their CD4 cell count is between 350 and 500 "appears to be beneficial over the long term.
› Verified 9 days ago
| Entity Name | The Mary Lanning Memorial Hospital Association |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1356656417 PECOS PAC ID: 4587575550 Enrollment ID: O20101007000817 |
News Archive
Patrick S. Smith, President and Chief Executive Officer of Curaxis Pharmaceutical Corp., today announced Curaxis' new listing on the Frankfurt Stock Exchange (FSE). Curaxis was at the FSE for its opening on February 8, 2011, and will trade under the symbol 8CX:GR.
Oxygen levels in the lab can permanently alter human embryonic stem (ES) cells, specifically inducing X chromosome inactivation in female cells, according to Whitehead Institute researchers. Human ES cells have been routinely created and maintained at atmospheric levels of oxygen, which is about 20%. Cells in the body are usually exposed to only 1-9% oxygen.
Rare inherited mutations in the body's master regulator of the DNA repair system – the TP53 gene – can leave people at a higher risk of developing multiple types of cancer over the course of their lives.
One reason cancer is so difficult to treat is that it avoids detection by the body. Agents of the immune system are constantly checking the surfaces of cells for chemical signals that say they belong, but cancer cells express the same chemical signals as healthy ones.
Findings from a study published in the current issue of the journal Archives of Internal Medicine, when "taken together with other studies published over the last few years," show that beginning people living with HIV on highly active antiretroviral therapy (HAART) when their CD4 cell count is between 350 and 500 "appears to be beneficial over the long term.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Paula A Loehr, CRNA 420 W 5th St Ste 101, Hastings, NE 68901-7551 Ph: (402) 463-9841 | Paula A Loehr, CRNA 715 N Saint Joseph Ave, Hastings, NE 68901-4451 Ph: (402) 463-9841 |
News Archive
Patrick S. Smith, President and Chief Executive Officer of Curaxis Pharmaceutical Corp., today announced Curaxis' new listing on the Frankfurt Stock Exchange (FSE). Curaxis was at the FSE for its opening on February 8, 2011, and will trade under the symbol 8CX:GR.
Oxygen levels in the lab can permanently alter human embryonic stem (ES) cells, specifically inducing X chromosome inactivation in female cells, according to Whitehead Institute researchers. Human ES cells have been routinely created and maintained at atmospheric levels of oxygen, which is about 20%. Cells in the body are usually exposed to only 1-9% oxygen.
Rare inherited mutations in the body's master regulator of the DNA repair system – the TP53 gene – can leave people at a higher risk of developing multiple types of cancer over the course of their lives.
One reason cancer is so difficult to treat is that it avoids detection by the body. Agents of the immune system are constantly checking the surfaces of cells for chemical signals that say they belong, but cancer cells express the same chemical signals as healthy ones.
Findings from a study published in the current issue of the journal Archives of Internal Medicine, when "taken together with other studies published over the last few years," show that beginning people living with HIV on highly active antiretroviral therapy (HAART) when their CD4 cell count is between 350 and 500 "appears to be beneficial over the long term.
› Verified 9 days ago
Troy L. Swayze, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 715 N Saint Joseph Ave, Hastings, NE 68901 Phone: 402-463-9841 Fax: 402-463-9846 | |
Larissa A. Luther Rossow, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 715 N Saint Joseph Ave, Hastings, NE 68901 Phone: 402-463-9841 | |
Christopher Brian Dennis, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 420 W 5th St, Hastings, NE 68901 Phone: 402-463-9841 | |
Melissa Berghuis, APRN, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 715 N Saint Joseph Ave, Hastings, NE 68901 Phone: 402-462-2139 Fax: 402-462-2381 | |
Judy A Appleby, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 420 W 5th St, Hastings, NE 68901 Phone: 402-463-9841 | |
Travis John Tonniges, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 420 W 5th St, Hastings, NE 68901 Phone: 402-463-9841 |